CLARIX: payments to doctors
Payments that named CLARIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 3,066
- Transactions
- 9,626
- Average per transaction
- $134
The per-transaction average — $134 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,066 providers the average total is $422, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amniox Medical, Inc. | $501,433 | 38.8% |
| Biotissue Holdings, Inc. | $303,375 | 23.5% |
| Biotissue Holdings Inc. | $296,589 | 22.9% |
| Tissuetech, Inc. | $191,104 | 14.8% |